Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B, PTP-alpha expression.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Gynecologic Oncology

• Publication date

  1996-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/GYNO.1996.0131PMID 8626139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein-tyrosine phosphatases.

  1994cited by this paper
• Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas.

  1994cited by this paper
• Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression.

  1994cited by this paper
• Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.

  1993cited by this paper
• Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13

  1992cited by this paper
• 1002 protein phosphatases?

  1992cited by this paper
• Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene.

  1992cited by this paper
• The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence.

  1992cited by this paper
• Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes.

  1991cited by this paper
• Isolation of a cDNA clone encoding a human protein-tyrosine phosphatase with homology to the cytoskeletal-associated proteins band 4.1, ezrin, and talin.

  1991cited by this paper
• A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases

  1991cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• A simplified method to culture human ovarian surface epithelium.

  1990cited by this paper
• Cloning and expression of a widely expressed receptor tyrosine phosphatase.

  1990cited by this paper
• Protein-tyrosine phosphatases: the other side of the coin.

  1989cited by this paper
• Growth factor receptor tyrosine kinases.

  1988cited by this paper
• Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins.

  1985cited by this paper
• Reactivity of a monoclonal antibody with human ovarian carcinoma.

  1981cited by this paper

• p210 bcr-abl In Vivo Signalling by Oncoprotein Tyrosine Kinase Protein Tyrosine Phosphatase 1B Antagonizes

  2013cites this paper
• Rosiglitazone attenuates tumor necrosis factor-α-induced protein-tyrosine phosphatase-1B production in HepG2 cells

  2011cites this paper
• PTP1B suppresses prolactin activation of Stat5 in breast cancer cells.

  2010cites this paper
• Functional analysis of the protein tyrosine phosphatase family in mammary epithelial cell models of breast cancer

  2010cites this paper
• Receptor tyrosine kinase alterations in AML - biology and therapy.

  2010cites this paper
• Drug discovery and protein tyrosine phosphatases.

  2009cites this paper
• Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.

  2007cites this paper
• Transforming Growth Factor β (TGF-β)-Smad Target Gene Protein Tyrosine Phosphatase Receptor Type Kappa Is Required for TGF-β Function

  2005cites this paper
• Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.

  2005cites this paper
• Characterization and Immune Targeting of a Novel Tumor Antigen, EphA2

  2004influential citation
• Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia

  2003cites this paper
• The Genetic Etiology of Sporadic Ovarian Cancer

  2003cites this paper
• Enzyme kinetic characterization of protein tyrosine phosphatases.

  2003cites this paper
• Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia.

  2003cites this paper
• CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential

  2002cites this paper
• Protein tyrosine phosphatases.

  2002cites this paper
• Cloning of hHRI, Human Heme-regulated Eukaryotic Initiation Factor 2α Kinase: Down-regulated in Epithelial Ovarian Cancers

  2000cites this paper
• Expression of protein tyrosine phosphatases and its significance in esophageal cancer.

  2000cites this paper
• Steroid hormone receptors and long term survival in invasive ovarian cancer

  2000cites this paper
• Molecular dynamics simulations of protein-tyrosine phosphatase 1B. II. substrate-enzyme interactions and dynamics.

  2000cites this paper
• Molecular aspects of ovarian cancer. Is gene therapy the solution?

  1999cites this paper
• p 210 bcr-abl In Vivo Signalling by Oncoprotein Tyrosine Kinase Protein Tyrosine Phosphatase 1 B Antagonizes

  1998cites this paper
• Protein Tyrosine Phosphatase 1B Antagonizes Signalling by Oncoprotein Tyrosine Kinase p210 bcr-abl In Vivo

  1998cites this paper